The global breast biopsy market size reached USD 2.96 Billion in 2022 and is expected to register a revenue CAGR of 5.7% during the forecast period, according to the latest analysis by Emergen Research. Growing developments in molecular imaging-related technologies is a key factor driving revenue growth of the market. One of the main factors driving market revenue growth is the expansion of research & development into the creation of breast biopsy platforms to treat chronic breast illnesses. The development of novel technologies is made possible by the rising research activities carried out by numerous institutions around the world.
The report studies the historical data of the Breast Biopsy market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimation of the Breast Biopsy industry based on the recent technological and research advancements. It also offers valuable data to assist the investors in formulating strategic business investment plans and capitalize on the emerging growth prospects in the Breast Biopsy market.
Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/1718
Competitive Terrain:
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Breast Biopsy market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Devicor Medical Products, Inc., ARGON MEDICAL., B. Braun Melsungen AG, Cardinal Health., Olympus Corporation, Boston Scientific Corporation, FUJIFILM Corporation, INRAD Inc., Medtronic, Hologic, Inc
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/breast-biopsy-market
Emergen Research has segmented the global Breast Biopsy market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
Type Outlook (Revenue, USD Billion; 2019-2032)
- Mammography
- MRI
- Others
Product Outlook (Revenue, USD Billion; 2019-2032)
- Vacuum Assisted Biopsy
- Core Needle Biopsy
- Others
Regional Outlook (Revenue, USD Billion; 2019–2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
- Analysis and estimation of the Breast Biopsy Market size and share for the projected period of 2022-2030
- Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Breast Biopsy Market
- Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
- Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1718
Latest Published Reports by Emergen Research:
Patient Monitoring Devices Market
Esoteric Testing Market
Content Services Platforms Market
Electronic Shelf Label Market
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
We specialize in performing breast surgery, breast biopsy and breast augmentation procedures in Texas.
Global breast biopsy devices market is forecasted to generate a revenue of $1.4 billion by 2023, P Market ResearchOn the basis of the procedure conducted for breast biopsy, the market is categorized into vacuum-assisted, core needle, fine needle aspiration, and surgical biopsy.
Vacuum-assisted biopsies have been accounting for the largest share in the breast biopsy devices market till now.
It is also expected to be the fastest growing category during the forecast period.
This can be mainly attributed to its various advantages, such as its ability to precisely locate the area of abnormality using imaging guidance, so that samples are removed only from the region of interest.Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/breast-biopsy-devices-market/report-sampleOn the basis of product, the breast biopsy devices market has been segmented into guidance systems, biopsy needles/guns, biopsy tables, biopsy wires, and other products.
Guidance systems are estimated to hold the largest share of 40.1%, in the market in 2017, with its demand majorly driven by the availability of stereotactic breast biopsy and tomosynthesis options in a single system, and the requirement of these systems in all types of surgeries.Globally, key players in the breast biopsy devices industry are launching products to gain a larger market share.
For instance, in November 2017, Siemens Healthineers, a subsidiary of Siemens AG, unveiled its new Mammomat Revelation imaging system at the 2017 Radiological Society of North America (RSNA) Annual Meeting in Chicago.
Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market.
Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.What the Market Looks Like?The report Breast Biopsy Market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period.Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805Market Segmentation:-Based on the product, the breast biopsy market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products.
In 2019, the biopsy needles held significant share of the market.
The major share of this segment is primarily attributed to the rising incidence of breast cancer and the growing breast cancer diagnosis rate in developing countries.Based on guidance, the Breast Biopsy Devices Market is segmented into image-guided biopsy and liquid biopsy.
The liquid biopsy segment is further divided into NGS-based, PCR-based, and Microarray-based biopsy.
Among these, the NGS-based biopsy segment is expected to register significant growth over the forecast period.Based on type, the Breast Biopsy Devices Market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy.
